Tissue scaffolds are essential for tissue engineering because they must provide a proper mechanical and chemical environment for seeded cells to grow and operate normally, eventually forming completely functioning tissue. Tissue scaffolds essentially serve two purposes: they give a place for cells to multiply and they have a structure that allows soluble gases, nutrients, and waste products to be transported in a way that satisfies the needs of an expanding cell population. Scaffolds for tissue engineering can also be made from natural materials and are generally biocompatible. For tissue engineering purposes, a variety of materials have been produced as scaffolds. Foaming is used to create scaffolds that most closely fulfill the parameters for an ideal scaffold and most closely mirror the structure of trabecular bone. Biocompatibility is the most important feature of TE scaffolds. Biocompatibility can be defined as a biomaterial's, device's, or system's capacity to fulfil its intended function in relation to a medical therapy without causing any undesired local or systemic consequences in the therapy's recipient or beneficiary. More specifically, a scaffold's biocompatibility for TE applications relates to its capacity to function as a substrate that will support the desired cellular activity.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States